Carsten Rudolph

This inventor holds 27 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 18 EPO patents. Top assignees: Ethris Gmbh, Translate Bio, Inc., Rana Therapeutics, Inc.. Active years: 2013-2026.

USPTO Granted Patents = 27 (Patent Applications = 6)

% Patents Active = 92.6

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 18 (Patent Applications = 27)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 134(Granted Patents)

Location History:

München, DE (2014 - 2017)
Munich, DE (2013 - 2020)
Martinsried, DE (2015 - 2021)
Planegg, DE (2019 - 2022)
Krailling, DE (2017 - 2024)
Krailing, DE (2021 - 2024)

Company Filing History:

Rana Therapeutics, Inc.

patents

4. 1 out of 86

Shire Human Genetic Therapies, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12728151 - TREATMENT OF CILIOPATHIES (2026-09-08),

2. 12697301 - Pulmonary Delivery of MRNA to Non-lung Target Cells (2026-08-04),

3. 12594295 - CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES (2026-04-07),

4. 12522821 - Polyribonucleotide containing deuterated nucleotides (2026-01-13),

5. 12263229 - Induction of osteogenesis by delivering BMP encoding RNA (2025-04-01),

6. 12064484 - Compositions for introducing RNA into cells (2024-08-20),

7. 11981910 - Minimal UTR sequences (2024-05-14),

8. 11510937 - CFTR MRNA compositions and related methods and uses (2022-11-29),

9. 11479768 - ATP-binding cassette family coding polyribonucleotides and formulations thereof (2022-10-25),

10. 11352638 - Minimal UTR sequences (2022-06-07),

11. 11136585 - UTRs increasing the translation efficiency of RNA molecules (2021-10-05),

12. 11104887 - Ornithine transcarbamylase coding polyribonucleotides and formulations thereof (2021-08-31),

13. 11090264 - Pulmonary delivery of mRNA to non-lung target cells (2021-08-17),

14. 11065346 - RNA for use in the treatment of ligament or tendon lesions (2021-07-20),

15. 11020487 - Compositions for introducing nucelic acid into cells (2021-06-01),

Title: The Innovative Mind of Carsten Rudolph

Introduction:

Carsten Rudolph, a distinguished inventor hailing from Krailling, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Carsten Rudolph's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Carsten Rudolph has established himself as a visionary in the tech industry. His work has revolutionized how we approach challenges in sectors such as healthcare, communication, and environmental sustainability.

Collaborations:

Throughout his career, Carsten Rudolph has collaborated with leading research institutions, universities, and tech companies worldwide. His partnerships have led to the development of innovative products and solutions that have had a lasting impact on society.

Conclusion:

In conclusion, Carsten Rudolph's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a trailblazer in the field. His work continues to inspire future generations of inventors and innovators.